national pharmaceutical, inc.

101-11 roosevelt ave
corona, new york 11368

NYS Entity Status
ACTIVE

NYS Filing Date
JUNE 16, 2014

NYS DOS ID#
4592745

County
QUEENS

Jurisdiction
NEW YORK

Registered Agent
NONE

NYS Entity Type
DOMESTIC BUSINESS CORPORATION

Name History
2014 - NATIONAL PHARMACEUTICAL, INC.









Buffer



submit to reddit

Telephone
n/a

Fax
n/a

Website
n/a

Email address
n/a

LinkedIn
n/a

Facebook
n/a

Google+
n/a

Twitter
n/a

Pinterest
n/a

Instagram
n/a



  • Around the Web

  • Impax Laboratories and Amneal Pharmaceuticals Near Merger Agreement
    Monday Oct 16, 2017

    Impax Laboratories Inc. and Amneal Pharmaceuticals LLC are close to agreement on a merger that would create the nation’s fifth-largest generic-drug company by revenue, according to people familiar with the matter.

    Source: The Wall Street Journal: U.S. Business
  • Stealthy NY Startup Rocket Pharma Merges With Inotek, Heads to Nasdaq
    By Ben Fidler - Tuesday Sep 12, 2017

    Rocket Pharmaceuticals, a stealthy gene therapy startup in New York City, has made its first splash. Through a merger with struggling Inotek Pharmaceuticals (NASDAQ: ITEK), Rocket, a company developing treatments for a variety of rare blood diseases, has taken itself public. Rocket shareholders are expected to own 81 percent of the combined company, with Inotek […]

    Source: Xconomy VC, Deals, & Startups Feed
  • The Look: New York City Parks in the Summer: Romance, Games and a Performance for a Dying Tree
    By DANIEL ARNOLD, JOANNA NIKAS and EVE LYONS - Saturday Sep 2, 2017

    Daniel Arnold spent the last two months photographing parks in all five boroughs. The experience showed him “a very different pulse of the city.”

    Source: NYT > Home Page
  • The Beer & Booze Company Behind Corona, Svedka & Mondavi Is Now Investing In Marijuana
    By Mary Beth Quirk - Monday Oct 30, 2017

    Instead of shrinking in fear from the rising green tide of legal marijuana, the parent company behind booze brands like Corona, Svedka, and Robert Mondavi is jumping right in with a big investment in the legal marijuana business.Constellation Brands Inc. is shelling out $191 million for a 9.9% stake in Canopy Growth Corp, a Canadian company — known as …

    Source: The Consumerist
  • A Drug Maker Spends Big in Washington to Make Itself Heard
    By JAY HANCOCK, ELIZABETH LUCAS and SYDNEY LUPKIN - Friday Jul 21, 2017

    Mallinckrodt’s spending on political donations and lobbying comes as the drug industry as a whole beefs up its Capitol Hill presence.

    Source: NYT > Home Page